Skip to Content
Skip to Footer
en-us
italiano
Sign In
Istituto Superiore di Sanità
Follow us on
About Us
Mission
Departments
National centres and Reference centres
Technical-scientific Services
History
Organization
Single guarantee committee
Regulations
ISS staff
Topics
Nutrition and food safety
Climate, environment and health
Dependencies
Medicines, vaccines and advanced therapies
Fertility
Gender and health
Clinical governance, National guidelines system (SNLG) and HTA
Chronic diseases and aging
Infectious diseases, HIV
Neurological diseases
Rare diseases
Prevention and health promotion
Radiation protection
Women's, children's and adolescents' health
Global health and health inequalities
Mental health
Veterinary public health
Chemical substances and health protection
Innovative technologies for health and telemedicine
Tumors
Activities
Databases
International collaborations
National Ethics Committee
Training
ISS-G20 Laboratorium
Reference laboratories
Guidelines - SNLG
Museum
Notified body
Projects
Publications
Registers and surveillance
Networks
School
Servizio Civile Universale
Phase 1 clinical trials
Services and Utilities
Meeting rooms
Calls and competitions
Library
Patronage
Intellectual property
Fares and paid services
Publications
Publications
Annali
Bollettino epidemiologico nazionale
Notiziario
Rapporti ISTISAN
Rapporti ISS Sorveglianza
ISS Activity Reports
ISS policy documents
Monographs
ISTISAN Congressi
Strumenti di riferimento
Rapporti ISS COVID-19
Rapporti ISS COVID-19 in English
Rapporti ISS COVID-19 en Español
Beni storico-scientifici
Dispense per la scuola
Consensus ISS
Leaflets
Historical videos
Ceased publications
Press Room
Home Page
About us
Press notes
News
Press releases
Press review
Special on COVID-19
Events
Digitale
Events
Conferences and seminars
Dissemination events
Webinar
ISSalute
Transparent administration
Tender notices
Data protection
MENU
Istituto Superiore di Sanità
About Us
Mission
Departments
National centres and Reference centres
Technical-scientific Services
History
Organization
Single guarantee committee
Regulations
ISS staff
Topics
Nutrition and food safety
Climate, environment and health
Dependencies
Medicines, vaccines and advanced therapies
Fertility
Gender and health
Clinical governance, National guidelines system (SNLG) and HTA
Chronic diseases and aging
Infectious diseases, HIV
Neurological diseases
Rare diseases
Prevention and health promotion
Radiation protection
Women's, children's and adolescents' health
Global health and health inequalities
Mental health
Veterinary public health
Chemical substances and health protection
Innovative technologies for health and telemedicine
Tumors
Activities
Databases
International collaborations
National Ethics Committee
Training
ISS-G20 Laboratorium
Reference laboratories
Guidelines - SNLG
Museum
Notified body
Projects
Publications
Registers and surveillance
Networks
School
Servizio Civile Universale
Phase 1 clinical trials
Services and Utilities
Meeting rooms
Calls and competitions
Library
Patronage
Intellectual property
Fares and paid services
Publications
Publications
Annali
Bollettino epidemiologico nazionale
Notiziario
Rapporti ISTISAN
Rapporti ISS Sorveglianza
ISS Activity Reports
ISS policy documents
Monographs
ISTISAN Congressi
Strumenti di riferimento
Rapporti ISS COVID-19
Rapporti ISS COVID-19 in English
Rapporti ISS COVID-19 en Español
Beni storico-scientifici
Dispense per la scuola
Consensus ISS
Leaflets
Historical videos
Ceased publications
Press Room
Home Page
About us
Press notes
News
Press releases
Press review
Special on COVID-19
Events
Digitale
Events
Conferences and seminars
Dissemination events
Webinar
ISSalute
Transparent administration
Tender notices
Data protection
Search Results - Home
Search
Search
Asset Entries
Any Asset
Web Content Article
(15)
Tags
Any Tag
faq vaccini
(2)
iss per covid 19
(2)
vaccini
(2)
Time
Any Time
Past Hour
(0)
Past 24 Hours
(0)
Past Week
(0)
Past Month
(0)
Past Year
(1)
Custom Range…
From
To
Search
No results were found that matched the keywords:
decessi covid-2019
.
Search
Can the vaccine cause
Covid
Web Content Article
technology is the same as that behind the first vaccine approved for Ebola in late
2019
...A possible
COVID
-19 disease following vaccination, can...
Newsroom:
Special on COVID-19
Special on COVID-19 » Vaccini
Special on COVID-19 » Vaccini » FAQ vaccini
Useful information - How does
Covid
affect children?
Web Content Article
Scarica tutte le card ISS 10 dicembre 2021 How does
Covid
affect children?...The safety of anti-
Covid
vaccines is continually monitored by...
Newsroom:
Special on COVID-19
Special on COVID-19 » Vaccini
Special on COVID-19 » Vaccini » FAQ vaccini
Vaccinated versus unvaccinated, a comparison between cases shows that the vaccine works
Web Content Article
. ·
COVID
-19 vaccination, as is the case with all vaccinations, does not protect...We currently know that if the full course of vaccination is administered, the...
Newsroom:
Special on COVID-19
Special on COVID-19 » Vaccini
Special on COVID-19 » Vaccini » FAQ vaccini
How is vaccine efficacy calculated?
Web Content Article
that vaccine efficacy in preventing any symptomatic or asymptomatic diagnosis of
COVID
Newsroom:
Special on COVID-19
Special on COVID-19 » Vaccini
Special on COVID-19 » Vaccini » FAQ vaccini
How does a viral vector-based vaccine workHow does a viral vector-based vaccine work?
Web Content Article
technology is the same as that behind the first vaccine approved for Ebola in late
2019
Newsroom:
Special on COVID-19 » Vaccini
Special on COVID-19 » Vaccini » FAQ vaccini
Can breastfeeding women be vaccinated against Sars-CoV-2?
Web Content Article
As previously envisaged in the interim guidance by the Istituto Superiore di Sanità – ISS (Italian National Institute of Health), breastfeeding women may get vaccinated, without any need to stop...
faq vaccini
vaccini
iss per covid 19
Newsroom:
Special on COVID-19
Special on COVID-19 » Vaccini » FAQ vaccini
Is the Sars-CoV-2 vaccine risky for people with celiac disease?
Web Content Article
There is no scientific evidence to suggest that people with celiac disease have a higher risk than the general population of developing adverse effects following the administration of the...
faq vaccini
vaccini
iss per covid 19
Newsroom:
Special on COVID-19
Special on COVID-19 » Vaccini » FAQ vaccini
Like all vaccines, Sars-Cov-2 vaccines can also cause side effects. During the trial, common reactions were observed, that were previously reported with other vaccinations. However, all countries that have adopted the vaccine, including Italy, have put in place a surveillance system for the reporting of adverse effects.
Web Content Article
In addition to not having the "instructions" to modify DNA, messenger RNA never enters the nucleus of the cell, which contains the genome; this means that messenger RNA can in no way alter DNA....
Newsroom:
Special on COVID-19 » Vaccini » FAQ vaccini
Special on COVID-19 » Vaccini
Special on COVID-19
What evidence is there of their safety, since they were approved so quickly?
Web Content Article
The tests required by the authorities and carried out on the candidate vaccines against Sars-Cov-2 are the same as for all the other previously approved drugs and vaccines. In Europe, it was...
Newsroom:
Special on COVID-19 » Vaccini » FAQ vaccini
Special on COVID-19 » Vaccini
Special on COVID-19
Are vaccines against Sars-CoV-2 effective
Web Content Article
In order to be approved by the regulatory authorities, all vaccines must have proven to be effective. Human trials of several dozen other candidates are underway around the world, some of which are...
Newsroom:
Special on COVID-19 » Vaccini » FAQ vaccini
Special on COVID-19 » Vaccini
Special on COVID-19
How long after being vaccinated doHow long after being vaccinated does an individual acquire protection against the virus?
Web Content Article
The efficacy observed in clinical trials refers to a few days after the administration of the second dose. Therefore, maximum protection occurs after this period. Although, according to preliminary...
Newsroom:
Special on COVID-19
Special on COVID-19 » Vaccini
Special on COVID-19 » Vaccini » FAQ vaccini
How does the risk of infection vary over time after vaccination?
Web Content Article
October 8th 2021 - When the first dose of the vaccine is administered, the risk of infection is the same as for unvaccinated persons because the immune system needs a few weeks to give rise to the...
Newsroom:
Special on COVID-19
Special on COVID-19 » Vaccini
Special on COVID-19 » Vaccini » FAQ vaccini
What are the side effects?
Web Content Article
December 12th 2021 - Like all vaccines, Sars-Cov-2 vaccines can also cause side effects. During the trial, common reactions were observed, that were previously reported with other vaccinations....
Newsroom:
Special on COVID-19 » Vaccini » FAQ vaccini
Special on COVID-19 » Vaccini
Special on COVID-19
RNA based vaccines will be used for the first time. What does that mean?
Web Content Article
December 24th 2020 - In a vaccine, the 'weakened' virus (or bacterium), or a part of it, is usually injected. The immune system recognizes the 'intruder' and produces antibodies that it will use...
Newsroom:
Special on COVID-19 » Vaccini » FAQ vaccini
Special on COVID-19 » Vaccini
Special on COVID-19
Quanto dura la protezione indotta dai vaccini anti-
COVID
-19?
Web Content Article
This result comes from the Italian version of this content.
Ad oggi non è nota la durata della protezione di questi vaccini. Tuttavia studi hanno osservato un declino della protezione indotta da tali vaccini dopo circa 5 mesi dal completamento del ciclo...
Newsroom:
Special on COVID-19 » Vaccini » FAQ vaccini
20 Entries
Per Page
4
Entries per Page
8
Entries per Page
20
Entries per Page
40
Entries per Page
60
Entries per Page
Showing 1 to 15 of 15 entries.
Previous Page
Page
1
Next Page
Hidden